Erratum to: Oleic Acid Ameliorates Amyloidosis in Cellular and Mouse Models of Alzheimer's Disease: Effects of Oleic Acid on Amyloidosis (Brain Pathology, (2011), 21, 3, (321-329), 10.1111/j.1750-3639.2010.00449.x);Oleic acid ameliorates amyloidosis in cellular and mouse models of alzheimer's disease

Brain Pathology

Volumn 21, Issue 3, 2011, Pages 321-329

  Amtul, Zareen ^a,b,c   Westaway, David ^d   Cechetto, David F ^b   Rozmahel, Richard F ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Alzheimer's disease; amyloid; Cos 7 cells; oleic acid; plaques; transgenic mice

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BRAIN PROTEIN; GAMMA SECRETASE; INSULINASE; MESSENGER RNA; OLEIC ACID; PRESENILIN; PRION PROTEIN; SOMATOMEDIN B;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; AMYLOID PLAQUE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL SECRETION; CELL STRAIN COS7; CHOLESTEROL INTAKE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME IMMUNOASSAY; FATTY ACID ANALYSIS; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; LIPID BRAIN LEVEL; LOW FAT DIET; MALE; MOUSE; NEOCORTEX; NONHUMAN; PROTEIN DIET; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 79954613332     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12512     Document Type: Erratum

References (47)

1. Ahren B, (1999) Plasma leptin and insulin in C57BI/6J mice on a high-fat diet: relation to subsequent changes in body weight. Acta Physiol Scand 165: 233-240. (Pubitemid 29090273)
2. Amtul Z, Uhrig M, Supino R, Beyreuther K, (2010) Phospholipids and a phospholipid-rich diet alter the in vitro amyloid-beta peptide levels and amyloid-beta 42/40 ratios. Neurosci Lett 481: 73-77.
3. Aoyagi T, Wada T, Nagai M, Kojima F, Harada S, Takeuchi T, et al, (1990) Deficiency of kallikrein-like enzyme activities in cerebral tissue of patients with Alzheimer's disease. Experientia 46: 94-97.
4. Askari B, Carroll MA, Capparelli M, Kramer F, Gerrity RG, Bornfeldt KE, (2002) Oleate and linoleate enhance the growth-promoting effects of insulin-like growth factor-I through a phospholipase d-dependent pathway in arterial smooth muscle cells. J Biol Chem 277: 36338-36344.
5. Brijbassi S, Amtul Z, Newbigging S, Westaway D, St George-Hyslop P, Rozmahel RF, (2007) Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo. Neurobiol Dis 25: 291-296. (Pubitemid 46124010)
6. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, et al, (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276: 21562-21570. (Pubitemid 37413154)
7. Crestini A, Napolitano M, Piscopo P, Confaloni A, Bravo E, (2006) Changes in cholesterol metabolism are associated with PS1 and PS2 gene regulation in SK-N-BE. J Mol Neurosci 30: 311-322. (Pubitemid 46568349)
8. Dore S, Kar S, Quirion R, (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci U S A 94: 4772-4777. (Pubitemid 27194319)
9. Ghribi O, Larsen B, Schrag M, Herman MM, (2006) High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol 200: 460-467. (Pubitemid 44107924)
10. Grimm MO, Grimm HS, Tomic I, Beyreuther K, Hartmann T, Bergmann C, (2008) Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels. J Biol Chem 283: 11302-11311.
11. Guan Z, Wang Y, Cairns NJ, Lantos PL, Dallner G, Sindelar PJ, (1999) Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol 58: 740-747. (Pubitemid 29328503)
12. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ, (1993) Beta-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268: 3021-3024. (Pubitemid 23070917)
13. Haass C, Capell A, Citron M, Teplow DB, Selkoe DJ, (1995) The vacuolar H(+)-ATPase inhibitor bafilomycin A1 differentially affects proteolytic processing of mutant and wild-type beta-amyloid precursor protein. J Biol Chem 270: 6186-6192.
14. Hartmann T, Bergsdorf C, Sandbrink R, Tienari PJ, Multhaup G, Ida N, et al, (1996) Alzheimer's disease betaA4 protein release and amyloid precursor protein sorting are regulated by alternative splicing. J Biol Chem 271: 13208-13214. (Pubitemid 26175902)
15. Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, et al, (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 18: 902-904.
16. Hwang DY, Cho JS, Kim CK, Shim SB, Jee SW, Lee SH, et al, (2005) Aging-related correlation of insulin-degrading enzyme with gamma-secretase- generated products involving insulin and glucose levels in transgenic mice. Neurochem Res 30: 1171-1177. (Pubitemid 41642161)
17. Iizuka T, Shoji M, Kawarabayashi T, Sato M, Kobayashi T, Tada N, et al, (1996) Intracellular generation of amyloid beta-protein from amyloid beta-protein precursor fragment by direct cleavage with beta- and gamma-secretase. Biochem Biophys Res Commun 218: 238-242.
18. Jensen M, Hartmann T, Engvall B, Wang R, Uljon SN, Sennvik K, et al, (2000) Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems. Mol Med 6: 291-302.
19. Kalvodova L, Kahya N, Schwille P, Ehehalt R, Verkade P, Drechsel D, Simons K, (2005) Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J Biol Chem 280: 36815-36823. (Pubitemid 41587762)
20. Kim YC, Ntambi JM, (1999) Regulation of stearoyl-CoA desaturase genes: role in cellular metabolism and preadipocyte differentiation. Biochem Biophys Res Commun 266: 1-4. (Pubitemid 30028757)
21. Kim YJ, Nakatomi R, Akagi T, Hashikawa T, Takahashi R, (2005) Unsaturated fatty acids induce cytotoxic aggregate formation of amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutants. J Biol Chem 280: 21515-21521. (Pubitemid 40805717)
22. Knops J, Suomensaari S, Lee M, McConlogue L, Seubert P, Sinha S, (1995) Cell-type and amyloid precursor protein-type specific inhibition of A beta release by bafilomycin A1, a selective inhibitor of vacuolar ATPases. J Biol Chem 270: 2419-2422.
23. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F, (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci U S A 98: 5815-5820. (Pubitemid 32435725)
24. Lichtenthaler SF, Ida N, Multhaup G, Masters CL, Beyreuther K, (1997) Mutations in the transmembrane domain of APP altering gamma-secretase specificity. Biochemistry 36: 15396-15403. (Pubitemid 27528006)
25. Liu Y, Yang L, Conde-Knape K, Beher D, Shearman MS, Shachter NS, (2004) Fatty acids increase presenilin-1 levels and [gamma]-secretase activity in PSwt-1 cells. J Lipid Res 45: 2368-2376. (Pubitemid 39602985)
26. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K, (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82: 4245-4249. (Pubitemid 15053619)
27. Mattson MP, (2004) Pathways towards and away from Alzheimer's disease. Nature 430: 631-639. (Pubitemid 39061671)
28. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K, (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 301: 41-52. (Pubitemid 23227174)
29. Moser HW, Moser AB, (1991) Measurement of Saturated Very Long Chain Fatty Acids in Plasma, pp. 177-191. Wiley-Liss Inc.: New York.
30. Nixon RA, (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120: 4081-4091.
31. Ntambi JM, (1999) Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res 40: 1549-1558. (Pubitemid 29418696)
32. Park YS, Jang HJ, Lee KH, Hahn TR, Paik YS, (2006) Prolyl endopeptidase inhibitory activity of unsaturated fatty acids. J Agric Food Chem 54: 1238-1242.
33. Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesbery WR, (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23: 81-88. (Pubitemid 28145695)
34. Qin W, Jia J, (2008) Down-regulation of insulin-degrading enzyme by presenilin 1 V97L mutant potentially underlies increased levels of amyloid beta 42. Eur J Neurosci 27: 2425-2432. (Pubitemid 351590916)
35. Roth RA, Mesirow ML, Yokono K, Baba S, (1984) Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme. Endocr Res 10: 101-112. (Pubitemid 14037221)
36. Smedman M, Potempska A, Rubenstein R, Ju W, Ramakrishna N, Denman RB, (1997) Effects of cadmium, copper, and zinc and beta APP processing and turnover in COS-7 and PC12 cells. Relationship to Alzheimer disease pathology. Mol Chem Neuropathol 31: 13-28.
37. St George-Hyslop PH, (2000) Molecular genetics of Alzheimer's disease. Biol Psychiatry 47: 183-199. (Pubitemid 30077395)
38. Stein TD, Anders NJ, DeCarli C, Chan SL, Mattson MP, Johnson JA, (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J Neurosci 24: 7707-7717. (Pubitemid 39186826)
39. Sun Y, Yao J, Kim TW, Tall AR, (2003) Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. J Biol Chem 278: 27688-27694. (Pubitemid 36899957)
40. Tagawa K, Maruyama K, Ishiura S, (1992) Amyloid beta/A4 precursor protein (APP) processing in lysosomes. Ann N Y Acad Sci 674: 129-137. (Pubitemid 23077401)
41. Uryu S, Tokuhiro S, Oda T, (2003) Beta-amyloid-specific upregulation of stearoyl coenzyme A desaturase-1 in macrophages. Biochem Biophys Res Commun 303: 302-305. (Pubitemid 36338240)
42. Wahrle S, Das P, Nyborg AC, McLendon C, Shoji M, Kawarabayashi T, et al, (2002) Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol Dis 9: 11-23. (Pubitemid 34174561)
43. Wilson DM, Binder LI, (1997) Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am J Pathol 150: 2181-2195. (Pubitemid 27233088)
44. Wolozin B, (2004) Cholesterol and the biology of Alzheimer's disease. Neuron 41: 7-10. (Pubitemid 38068431)
45. Xiong H, Callaghan D, Jones A, Walker DG, Lue LF, Beach TG, et al, (2008) Cholesterol retention in Alzheimer's brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiol Dis 29: 422-437.
46. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, et al, (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407: 48-54.
47. Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, et al, (2007) Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 27: 3639-3649. (Pubitemid 46557686)